ASGE Postgraduate Course at ACG 2022: Expanding the Scope of Fundamental and Advanced Endoscopy (On-Demand) | October 2022-Point Counterpoint: Risk Stratification and Selection is Key for Barrett's Ablation

Point Counterpoint: Risk Stratification and Selection is Key for Barrett's Ablation

Video Transcription

Video Summary

In this video, Sachin Vani from the University of Colorado discusses risk stratification and selection for Barrett's ablation. He begins by explaining the low risk of progression in patients with nondisplastic Barrett's esophagus, emphasizing that ablation is not recommended for all patients in this category. Vani then discusses the challenges in managing patients with low-grade dysplasia, highlighting the variability in progression rates and the phenomenon of regression. He reviews the available data on surveillance versus endoscopic eradication therapy for low-grade dysplasia and argues against uniform ablation for all patients. Vani also mentions the limitations of current surveillance practices and the importance of performing high-quality examinations. He concludes by discussing risk stratification tools and the need for prospective trials to validate these tools. The video is presented by Sachin Vani from the University of Colorado and is a part of a course organized by ASGE.

Asset Subtitle

Sachin B. Wani, MD, FASGE

Keywords

risk stratification

Barrett's ablation

low-grade dysplasia

surveillance

prospective trials